Janssen solicita la autorización de macitentán y tadalafilo para HAP
Janssen presenta una solicitud de autorización de comercialización ante la Agencia Europea de Medicamentos para la aprobación de la terapia
Read MoreJanssen presenta una solicitud de autorización de comercialización ante la Agencia Europea de Medicamentos para la aprobación de la terapia
Read MoreLos datos más recientes del estudio fase 3 A DUE muestran que la terapia combinada experimental de macitentán y tadalafilo en un
Read MoreEl objetivo de PHuman es proporcionar a los pacientes con Hipertensión Arterial Pulmonar una herramienta sencilla y accesible que les
Read MoreCookie | Duración | Descripción |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |